Background: Sarcopenia is a disorder causing age-related loss of muscle mass. Its multifaceted nature has been linked to an increased risk of disability and mortality. Equally, obesity is a well-known risk factor for a host of disorders. A combination of sarcopenia and obesity in elderly diabetics can synergistically lead to increased insulin resistance and risk of metabolic syndrome. This study aimed to identify the association between sarcopenia and obesity in elderly diabetic patients by a cost-effective anthropometric method. Methods: A case-control study was conducted from January 2016 to April 2016 at Dr. B. R. Ambedkar Medical College in Bangalore. Height, weight, mid-arm circumference, and triceps skin fold thickness of 112 diabetic patients and 131 healthy adults were measured. Descriptive statistical analysis and multiple linear regression analysis were carried out. Results: 26.8% of male and 76.8% of female diabetic patients were obese (body mass index ≥25 kg/m
Introduction
"Successful ageing''-a capacity to maintain quality of life, health, and independence in later years of life-is a challenging issue. In order to minimize disability and chronic ailments, it is imperative to identify lifestyle, health, and social factors that would impact functional ability of elderly individuals. 1 One of the most common health disorders affecting elderly individuals is diabetes mellitus. Diabetes and its complications take a major toll on the quality of life in elderly patients, with increased risk of cardiovascular mortality and health care costs of the society. 2 Most striking changes in elderly diabetic patients are obesity and decreased skeletal muscle mass. 1 Reduction in skeletal muscle mass is termed "sarcopenia", which comes from Greek words "sarx", for flesh, and "penia", for loss. 3 The molecular basis for the effects of sarcopenia is that skeletal muscle is one of the primary sites for glucose uptake and storage, and myokines secreted by skeletal muscle counteract the metabolic and pro-inflammatory effects of adipocytes. The combined effect of sarcopenia and obesity can increase the risk of developing metabolic and cardiovascular diseases. 4 Many methods are available for the evaluation of sarcopenia, such as computed tomography, magnetic resonance imaging, dual energy X-ray absorptiometry, prediction using total body potassium, and creatinine excretion. These methods are expensive, and anthropometry is a cost-effective alternative method to estimate sarcopenia and obesity with considerable accuracy. 5 A previous study comparing these methods has proven anthropometry to be an easy and inexpensive method. 6 The need for the present study was to examine if an anthropometrical association exists between sarcopenia and obesity. Muscle mass and body mass indices were measured with parameters such as height, weight, corrected arm muscle area, and triceps skinfold thickness to identify the association between sarcopenia and obesity.
Methods

Ethics Statement
Written informed consent was obtained from all the partici- Diabetic patients with history of renal disorder, liver disorder, cancer, organ failure and those who had previously undergone limb amputation were excluded. In normal subjects, history of diabetes, stroke, coronary artery disease, cancer, liver cirrhosis, hypertension, and organ failure were ruled out. In both the case and control groups, history of smoking and alcohol consumption were elicited, and individuals with such history were excluded.
Original Article
Based on the history of diabetes and age, the participants were stratified into case (i.e. those with diabetes and age >60) and control groups (i.e. those without history of diabetes and aged <60), taking into consideration the exclusion criteria for both groups.
Anthropometric Measurements and Statistical Analysis
Anthropometric measurements of height, weight, mid-arm circumference and triceps skin fold thickness were taken based on the following methods: (1) weight was measured to the nearest 0.1 kg in light clothes without footwear, using a digital scale; (2) standing height was measured using a height scale fixed to the wall and was measured to the nearest 0.1 cm; (3) a point midway between the tip of acromion process of scapula and olecranon process was marked with the participant's arm flexed at 90°, and this point was used to calculate mid-arm circumference to the nearest 0.1 cm; and (4) triceps skin fold thickness was measured over the same point on the posterior aspect of arm over the triceps muscle using a Holtain caliper to the nearest 0.1 cm. 7 Body mass index was calculated by dividing weight (kg) with the square of height (in meters), and obesity was defined as body mass index ≥25 kg/m 2 in our study population. 8 The midarm circumference (MAC) and triceps skin fold thickness (TSF) were used to calculate the corrected arm muscle area (CAMA) using the formula: CAMA = [MAC − (π × TSF)] 2 /4π − BA (BA is correction for bone area, which is 10 cm 2 for males and 6.5 cm 2 for females). 6 Muscle mass was calculated with corrected arm muscle area and triceps skin fold thickness using the formula: muscle mass (kg) = height × (0.0264 + 0.0029 × CAMA). 6 Sarcopenia was defined as muscle mass more than one standard deviation below the mean of the young reference population (cut off values were <9.79 kg/m 2 for diabetic males and <8.53 kg/m 2 for diabetic females). SPSS software version 21 was used for statistical analysis. Descriptive statistical analysis was done to calculate geometric means and standard deviations for variables such as age, body height, body weight, body mass index, mid-arm circumference, triceps skin fold thickness, corrected arm muscle area and muscle mass of normal and elderly diabetic patients. Multiple linear regression analysis was done to obtain the relationship between the dependent variables (body mass index and muscle mass) and the three independent variables age, height and weight. ANOVA test was administered to find out the breakdown of variance between groups (normal males, normal females, diabetic males and diabetic females) in parameters like muscle mass and body mass index.
Results
131 non-diabetic participants and 112 elderly diabetic patients contributed to the anthropometric data. The mean (with standard deviation) age, height, weight, body mass index, mid-arm circumference, triceps skin fold thickness, corrected arm muscle area and muscle mass for both the case and control groups are presented in Table 1 .
Out of 112 elderly diabetic patients, 8.9% patients had sarcopenia (male: 12.5%; female: 5.4%). The prevalence of obesity among elderly diabetic patients were 26.8% for males and 76.8% for fema- Multiple linear regression analysis was performed to identify predictors of muscle mass, with muscle mass being the dependent variable and predictors being age, height and weight. The R 2 value indicated that 67% of the variance in muscle mass was explained by variance in the three predictor variables. β values indicated that weight had greater influence on muscle mass (β = 0.605) than age (β = 0.216).
Discussion
We compared the association of muscle mass and body mass index in elderly diabetic patients (male and female patients aged ≥60 years) with normal participants aged 17-58 years who had no history of diabetes mellitus. In normoglycemic individuals, corrected arm muscle area and triceps skin fold thickness correlated positively with body mass index, suggestive of their role in the magnitude of body mass index. In elderly diabetic individuals, triceps skin fold thickness was more closely related to body mass index than muscle mass. We found an average association between obesity and sarcopenia in the participants with diabetes mellitus.
Skeletal muscle composition estimated using upper arm anthropometry is a key diagnostic method for identifying geriatric syndromes associated with sarcopenia. 7 Among various anthropometric methods available to determine sarcopenia, a simple formula "fat-free muscle mass index = fat-free mass (kg)/ height 2 (m 2 )" was proposed in 2013, with sarcopenia defined as two standard deviations less than young adult reference population. 9 With dual energy X-ray absorptiometric technique, muscle mass can be estimated by the formula "skeletal muscle mass index = appendicular skeletal muscle mass (kg)/height 2 (m 2 )", with sarcopenia defined as values lower than 7.36 kg/ m 2 for men and 5.81 kg/m 2 for women. 10 Based on the fact that sarcopenia and obesity act synergistically on metabolic and functional impairments in elderly, the formula "appendicular muscle mass/body weight" was used to define sarcopenic obesity. 11, 12 However, Bret in 1997 proposed that upper body fat distribution heightens the risk for insulin resistance and metabolic syndrome. 13 This is the basis for the calculation of muscle mass using Heymsfield formula with parameters such as corrected arm muscle area and triceps skin fold thickness in the present study. 6 The possible association of muscle mass and body mass index can be explained by their interaction at molecular level. Age-related muscle wasting leads to reduced physical activity and induces accumulation of visceral fat. Increase in abdominal fat particularly may release pro-inflammatory cytokines, tumor necrosis factor-α (TNF-α) and leptin. This causes fatty infiltration in the muscle tissue and contributes to loss of muscle mass. Thus, obesity can hasten the process of reduction of muscle mass.
14 In earlier studies, leg muscle mass has been considered to be an important determinant of central arterial stiffness. Increase in the muscle mass can increase the requirement of blood supply resulting in higher cardiac output and stroke volume. This can contribute to larger size adaptation of arteries. 7 Insulin resistance in diabetic individuals with sarcopenia can be attributed to greater lipolytic activity of centrally located adipocytes. Portal venous elevation of fatty acids decreases the hepatic insulin extraction and promotes the synthesis of apolipoprotein-B and lipoproteins. Obesity and sarcopenia can thus result in hyperinsulinemia. 9 A cross-sectional study of lean young Indian men showed that muscle metabolism significantly correlated with glucose disposal rate. This was suggestive of the fact that muscle is an important location for glucose disposal and therefore insulin sensitivity. 15 A study in Korean population conducted in 2009-2010 has shown that sarcopenia may be an early predictor for insulin resistance, diabetes mellitus and metabolic syndrome. 16 A similar study conducted among elderly Korean adults in 2008-2010 revealed that there was a strong association between hypertension and sarcopenia. 16 The risk of hypertension was found to be four-fold higher in diabetic patients with sarcopenic obesity. Note, however, that heavy alcohol consumption and smoking had to be taken into account while assessing the relationship between sarcopenia and hypertension. 11 In addition, a Japanese study has proven that physical activity of moderate intensity (>15-20 minutes/day) maintained muscle mass beyond sarcopenia threshold. 1 In the present study, muscle mass showed an average relationship with body mass index in diabetic patients. Several prior studies have indicated that lower muscle mass has a greater influence on insulin sensitivity in diabetic patients than fat distribution. [17] [18] [19] [20] [21] [22] [23] [24] [25] In addition, earlier studies on the combined effects of obesity and lower muscle mass in older persons on physical functioning have suggested that older patients with sarcopenic obesity had two-fold greater risk of developing instrumental activities of daily living disability than those without sarcopenic obesity. 1 Bedside estimation of muscle mass by anthropometry has proven to be of prognostic and therapeutic value. A screening method using anthropometric prediction equation can be a cost-effective diagnostic tool for determining sarcopenia in elderly individuals in primary health care settings. Such screening programs followed by confirmatory diagnosis of sarcopenia with dual energy X-ray absorptiometry would be beneficial to support early treatment of diabetes mellitus. 26 Cautions must be taken in the assessment of muscle mass, as anthropometrical muscle mass could change independently from muscle composition, especially in cases of protein energy malnutrition. In severe protein energy malnutrition, the water content increase per gram of wet muscle tissue, masking to some extent losses of muscle functional protein. 6 The present study provides baseline data of muscle mass of community-based elderly diabetic population in Bangalore, India. The accuracy and reliability of the findings are limited by the potential errors in the anthropometric measurements. Highly trained observers and frequent measurements are required for diagnostic accuracy, for there could be individual variability in the measurement of triceps skin fold thickness and mid-arm circumference area. There is also a need to develop a non-invasive anthropometric method to determine muscle mass index with desirable diagnostic accuracy which could serve as a screening tool for measuring muscle strength rather than muscle mass.
In conclusion, there was a positive correlation between muscle mass and body mass index in elderly diabetic patients. The prevalence of obesity in elderly diabetic patients were 76.8% and 26.8% among female and male patients, respectively. Our study concurs with earlier studies which have proven that muscle strength, rather than muscle mass, is beneficial for establishing relationship between muscle mass and body mass index. Further studies are needed to establish the relationship between muscle strength and body mass index.
